Signed · United Kingdom · Pharma and biotech
SenzaGen agrees to acquire Alcyomics.
SenzaGen, based in Lund, Sweden, signed an agreement on 28 October 2026 to acquire all shares in Alcyomics, a Newcastle-based provider of non-animal immunotoxicology testing for preclinical drug development. Completion is expected around 4 November 2026. It was signed on 28 October 2026. It had not completed by 29 October 2026.
Signing 28 October 2026
- Buyer
- SenzaGen AB (publ) ·Lund, Sweden
- Target
- Alcyomics Ltd ·Newcastle, United Kingdom
- Type
- Acquisition
- Announced
- 28 October 2026
- Signed
- 28 October 2026
- Value
- about GBP 2.12 million (initial price)
- People
- Not stated in the release
- Last checked
- 29 October 2026
The people side in the United Kingdom
- In a business transfer or service provision change, staff move to the buyer on their existing terms; a dismissal solely or mainly because of the transfer is unfair. Transfer of Undertakings (Protection of Employment) Regulations 2006, regulations 4 and 7
- Long enough before a TUPE transfer, the employer informs staff representatives and consults on any measures envisaged; failure can cost up to 13 weeks' pay per affected employee. Transfer of Undertakings (Protection of Employment) Regulations 2006, regulations 13 and 16
- Acas guidance says TUPE is not likely to apply to a transfer of shares only, as in a share deal. Acas: TUPE, advice for employers and employees
- Buying over 25% of an entity in one of 17 sensitive areas in the UK needs approval before completion, or the deal is void; the first review takes up to 30 working days. GOV.UK: Check if you need to tell the government about an acquisition that could harm the UK's national security (National Security and Investment Act 2021)
- A business that starts employing staff in the UK registers with HMRC as an employer before the first payday, and not more than 2 months before it starts paying people. GOV.UK: Register as an employer
- SenzaGen press release (MFN), 28 October 2026 (primary source)
Related deals
- 19 Oct
Merck KGaAto
Silence Therapeutics plcdeal page: Merck KGaA agrees to acquire Silence TherapeuticsSigned
not statedSigningDay 100 - 26 Oct
Uniwater ABto
Hy-Ram Engineeringdeal page: Uniwater acquires Hy-Ram EngineeringCompleted
56SigningDay 100 - 26 Oct
Lifco ABto
Maxlightdeal page: Lifco agrees to acquire MaxlightSigned
50SigningDay 100 - 22 Oct
Addtech ABto
Connectors & Switchgear Ltddeal page: Addtech acquires Connectors & SwitchgearCompleted
42SigningDay 100